Albion Financial Group
- SEC CIK
- 0001054677
- Latest filing
- Jul 22, 2026
AXDX holding history
Accelerate Diagnostics, Inc in every 13F filed by Albion Financial Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXDX overviewAll 13F holders of AXDXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −212−100.0% | Sold out | Holders |
| Q1 2025 | 212 | $149 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 212 | $255 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 212 | $363 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 212 | $249 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 212 | $210 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 212 | $832 | <0.1% | −1,500−87.6% | Reduced | Holders |
| Q3 2023 | 1,712 | $9.84K | <0.1% | +1,712 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −2,125−100.0% | Sold out | Holders |
| Q1 2023 | 2,125 | $1.49K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 2,125 | $1.50K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,125 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,125 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,125 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 2,125 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,125 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 2,125 | $17.0K | <0.1% | – | No prior filing | Holders |